Case Details for "BioForm Medical, Inc"

Investigation of BioForm Medical, Inc. Over Acquisition

Lawyers are investigating potential claims on behalf of shareholders of BioForm Medical, Inc. ("BioForm" or the "Company") (Nasdaq: BFRM) arising from the Company's announcement of its intent to be acquired by Merz Pharma Group ("Merz").

On January 4, 2010, BioForm announced its plan to merge with Merz. Under the terms of the merger agreement, BioForm shareholders will receive $5.45 in cash for every share of BioForm stock they own in a transaction valued at $253 million.

The investigation is focused on the potential unfairness of the consideration to be paid to BioForm shareholders as well as the potential unfairness of the process by which the BioForm Board of Directors is addressing the transaction.

Posted on:01/05/2010
Company: BioForm Medical, Inc
Affected Class: Current Shareholders
Scope: Nationwide

Contact Us Regarding This Investigation:

First Name
Last Name
Email Address
Phone Number
State of Residence	Please select Outside of US or Canada Canada Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District Of Columbia Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Palau Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virgin Islands Virginia Washington West Virginia Wisconsin Wyoming
Name of Company At Issue
Description / Explanation
Security Code Please enter the code provided in the text box to submit this form.